To fully realize the potential of AI and digital, biopharma sponsors need a structured approach to upgrading tech infrastructure for efficient data capture and trial management.
To fully realize the potential of AI and digital, biopharma sponsors need a structured approach to upgrading tech infrastructure for efficient data capture and trial management.